NADMED
NADMED provides CE-marked and research-use-only (RUO) kits for the precise measurement of NAD and glutathione metabolites from blood, tissue, and cell samples. The company offers laboratory services for redox metabolite analysis and supplement purity testing to support clinical trials, drug development, and personalized medicine. Its proprietary extraction method enables professional laboratories and healthcare providers to quantify all four forms of NAD and two glutathione species with accuracy matching mass spectrometry.
Visit websiteHelsinki, Finland
Healthtech
Biotechnology
Diagnostics
Life Sciences
Funding summary
- Total raised
- €3.5M
- Funding rounds
- 1
Investors in NADMED
Investors on record for NADMED. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like NADMED?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors